ED Agitation Management: Sedation Options & Pearls | Clinical Guide

Added:

Agitation Case
General Approach
First-Gen Antipsychotics
Second-Gen Antipsychotics
Benzodiazepines & Combo
Agent Selection
ED Down Summary

Agitation Case

0:03
Playing Section
  • 1

    Presents a 42-year-old agitated patient with psychiatric history and abnormal vitals.

  • 2

    Initial steps focus on ruling out hypoglycemia and attempting verbal de-escalation.

  • 3

    Physical restraints are considered when verbal methods fail and safety is at risk.

Basic pharmacology of common sedative classes, including benzodiazepines, typical and atypical antipsychotics, and dissociative agents like ketamine.
The clinical presentation and differential diagnosis of acute agitation, specifically distinguishing between organic causes (e.g., hypoglycemia, hypoxia, toxidromes) and psychiatric etiologies.
Non-pharmacological de-escalation techniques and verbal strategies used to manage escalating patient behavior before resorting to chemical restraints.
Foundational concepts of airway management and patient monitoring, including how to assess respiratory drive and cardiovascular stability.
Advanced management protocols for Excited Delirium Syndrome (ExDS) and severe, refractory agitation that does not respond to first-line agents.
The ethical, legal, and institutional frameworks governing the use of chemical and physical restraints in the emergency department.
Post-sedation care and monitoring, including the identification and emergency management of drug-induced adverse events such as QTc prolongation, extrapyramidal symptoms, and respiratory depression.
Crisis Resource Management (CRM) principles, focusing on team communication, role assignment, and safety measures during high-stress behavioral emergencies.
309 views4likes12:34@KingsofCountyEMOriginal Release: 2021-12-11

Effective management of agitated patients requires a systematic approach beginning with verbal de-escalation and ensuring personal safety, followed by appropriate pharmacological intervention based on patient characteristics: first-generation antipsychotics (haloperidol 2.5-5mg IM, onset 27min, half-life 20h) are preferred for elderly patients and those with psychotic disorders but carry black box warnings; second-generation antipsychotics (olanzapine 5-10mg IM, onset 30min, half-life 30h) offer reduced EPS risk and better preservation of patient cooperation; benzodiazepines (midazolam 2-5mg IM, onset 15min; lorazepam 2mg IM, onset 32min) are effective for anxiety and alcohol withdrawal but may cause paradoxical reactions; ketamine (4-5mg/kg IM, onset 4-5min) provides the fastest onset but requires airway monitoring; special populations require dose adjustments (elderly: half-dose, slower redosing; pediatric: fluids first, then oral/IM; pregnant: benadryl first, antipsychotics/benzos relatively safe for single ED doses).